Download PDF
Thorac Cardiovasc Surg 2019; 67(08): 665-671
DOI: 10.1055/s-0039-1692409
Original Cardiovascular
Georg Thieme Verlag KG Stuttgart · New York

Prognostic Factors for Long-Term Survival after Surgical Resection of Primary Cardiac Sarcoma

Anas Aboud
1   Department of Cardiac and Thoracic Vascular Surgery, University of Schleswig-Holstein, Lübeck Campus, Lübeck, Germany
,
Kassar Farha
2   Department of Thoracic and Cardiovascular Surgery, Heart and Diabetes Center NRW, Ruhr-University Bochum, Bad Oeynhausen, Germany
,
Wan Chin Hsieh
3   Department of Cardiovascular Surgery, First Faculty of Medicine, General University Hospital in Prague, Charles University, Prague, Czech Republic
,
Frank Brasch
4   Department of Pathology, Academic Teaching Hospital Bielefeld, Bielefeld, Germany
,
Stephan Ensminger
1   Department of Cardiac and Thoracic Vascular Surgery, University of Schleswig-Holstein, Lübeck Campus, Lübeck, Germany
,
Jan Gummert
2   Department of Thoracic and Cardiovascular Surgery, Heart and Diabetes Center NRW, Ruhr-University Bochum, Bad Oeynhausen, Germany
,
André Renner
2   Department of Thoracic and Cardiovascular Surgery, Heart and Diabetes Center NRW, Ruhr-University Bochum, Bad Oeynhausen, Germany
› Author Affiliations
Further Information

Publication History

20 February 2019

29 April 2019

Publication Date:
27 June 2019 (online)

   Permissions and Reprints All articles of this category

Abstract

Background Primary cardiac sarcoma (CS) is an extremely rare disease. This study aims to identify possible prognostic factors for long-term survival.

Methods A total of 17 consecutive patients who were treated for primary CS between 2003 und 2018 at two cardiac centers were investigated. Clinical data and histological characteristics of the tumors were analyzed. Long-term follow-up of all patients were performed.

Results The median age was 54 years (range: 23–74). The tumors originated from the left side of the heart in nine patients. Histologically, there were four angiosarcomas, three intimal sarcomas, and three synovial sarcomas. One- and 7-year survivals were 81.9 and 18.2%, respectively. Low expression levels of Ki-67 tended to be associated with increased survival (log-rank p = 0.06). Adjuvant chemotherapy but not radiotherapy regardless of existing metastases was associated with significantly increased survival (log-rank p = 0.001).

Conclusion Angiosarcoma was the most common type of CS. The survival of CS patients is poor but prognostic factors, such as Ki-67, may help estimate the course of the disease. Survival could be improved significantly with chemotherapy.

Keywords

sarcoma - outcomes - histopathology
 

  • References

  • 1 Straus R, Merliss R. Primary tumors of the heart. Arch Pathol (Chic) 1945; 39: 74-78
    PubMedGoogle Scholar
  • 2 Kim CH, Dancer JY, Coffey D. , et al. Clinicopathologic study of 24 patients with primary cardiac sarcomas: a 10-year single institution experience. Hum Pathol 2008; 39 (06) 933-938
    CrossrefPubMedGoogle Scholar
  • 3 Castillo JG, Silvay G. Characterization and management of cardiac tumors. Semin Cardiothorac Vasc Anesth 2010; 14 (01) 6-20
    CrossrefPubMedGoogle Scholar
  • 4 Look Hong NJ, Pandalai PK, Hornick JL. , et al. Cardiac angiosarcoma management and outcomes: 20-year single-institution experience. Ann Surg Oncol 2012; 19 (08) 2707-2715
    CrossrefPubMedGoogle Scholar
  • 5 Burazor I, Aviel-Ronen S, Imazio M. , et al. Primary malignancies of the heart and pericardium. Clin Cardiol 2014; 37 (09) 582-588
    PubMedGoogle Scholar
  • 6 Patel SD, Peterson A, Bartczak A. , et al. Primary cardiac angiosarcoma - a review. Med Sci Monit 2014; 20: 103-109
    CrossrefPubMedGoogle Scholar
  • 7 Ramlawi B, Leja MJ, Abu Saleh WK. , et al. Surgical treatment of primary cardiac sarcomas: review of a single-institution experience. Ann Thorac Surg 2016; 101 (02) 698-702
    CrossrefPubMedGoogle Scholar
  • 8 Glancy DL, Morales Jr JB, Roberts WC. Angiosarcoma of the heart. Am J Cardiol 1968; 21 (03) 413-419
    CrossrefPubMedGoogle Scholar
  • 9 Janigan DT, Husain A, Robinson NA. Cardiac angiosarcomas. A review and a case report. Cancer 1986; 57 (04) 852-859
    CrossrefPubMedGoogle Scholar
  • 10 Butany J, Yu W. Cardiac angiosarcoma: two cases and a review of the literature. Can J Cardiol 2000; 16 (02) 197-205
    PubMedGoogle Scholar
  • 11 Hoffmeier A, Sindermann JR, Scheld HH, Martens S. Cardiac tumors--diagnosis and surgical treatment. Dtsch Arztebl Int 2014; 111 (12) 205-211
    PubMedGoogle Scholar
  • 12 Leduc C, Jenkins SM, Sukov WR, Rustin JG, Maleszewski JJ. Cardiac angiosarcoma: histopathologic, immunohistochemical, and cytogenetic analysis of 10 cases. Hum Pathol 2017; 60: 199-207
    CrossrefPubMedGoogle Scholar
  • 13 Lam KY, Dickens P, Chan AC. Tumors of the heart. A 20-year experience with a review of 12,485 consecutive autopsies. Arch Pathol Lab Med 1993; 117 (10) 1027-1031
    PubMedGoogle Scholar
  • 14 Mayer F, Aebert H, Rudert M. , et al. Primary malignant sarcomas of the heart and great vessels in adult patients--a single-center experience. Oncologist 2007; 12 (09) 1134-1142
    CrossrefPubMedGoogle Scholar
  • 15 Burke A, Jeudy Jr J, Virmani R. Cardiac tumours: an update: cardiac tumours. Heart 2008; 94 (01) 117-123
    CrossrefPubMedGoogle Scholar
  • 16 Kumar N, Agarwal S, Ahuja A, Das P, Airon B, Ray R. Spectrum of cardiac tumors excluding myxoma: experience of a tertiary center with review of the literature. Pathol Res Pract 2011; 207 (12) 769-774
    CrossrefPubMedGoogle Scholar
  • 17 Miettinen M. Immunohistochemistry of soft tissue tumours - review with emphasis on 10 markers. Histopathology 2014; 64 (01) 101-118
    CrossrefPubMedGoogle Scholar
  • 18 Sorbye SW, Kilvaer TK, Valkov A. , et al. Prognostic impact of CD57, CD68, M-CSF, CSF-1R, Ki67 and TGF-beta in soft tissue sarcomas. BMC Clin Pathol 2012; 12: 7
    CrossrefPubMedGoogle Scholar
  • 19 Sorbye SW, Kilvaer TK, Valkov A. , et al. Prognostic impact of Jab1, p16, p21, p62, Ki67 and Skp2 in soft tissue sarcomas. PLoS One 2012; 7 (10) e47068
    CrossrefPubMedGoogle Scholar
  • 20 Levenson RM, Borowsky AD, Angelo M. Immunohistochemistry and mass spectrometry for highly multiplexed cellular molecular imaging. Lab Invest 2015; 95 (04) 397-405
    PubMedGoogle Scholar
  • 21 Pucci A, Gagliardotto P, Zanini C, Pansini S, di Summa M, Mollo F. Histopathologic and clinical characterization of cardiac myxoma: review of 53 cases from a single institution. Am Heart J 2000; 140 (01) 134-138
    CrossrefPubMedGoogle Scholar
  • 22 Li LT, Jiang G, Chen Q, Zheng JN. Ki67 is a promising molecular target in the diagnosis of cancer (review). Mol Med Rep 2015; 11 (03) 1566-1572
    CrossrefPubMedGoogle Scholar
  • 23 Fletcher C, Unni K, Mertens F. Pathology and genetics of tumors of soft tissue and bone. World Health Organization Classification of Tumors. Lyon: IARC Press; 2002: 10-18
    Google Scholar
  • 24 Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481
    CrossrefPubMedGoogle Scholar
  • 25 Putnam Jr JB, Sweeney MS, Colon R, Lanza LA, Frazier OH, Cooley DA. Primary cardiac sarcomas. Ann Thorac Surg 1991; 51 (06) 906-910
    CrossrefPubMedGoogle Scholar
  • 26 Li H, Yang S, Chen H. , et al. Survival after heart transplantation for non-metastatic primary cardiac sarcoma. J Cardiothorac Surg 2016; 11 (01) 145
    CrossrefPubMedGoogle Scholar
  • 27 Eckstein R, Gössner W, Rienmüller R. Primary malignant fibrous histiocytoma of the left atrium. Surgical and chemotherapeutic management. Br Heart J 1984; 52 (03) 354-357
    CrossrefPubMedGoogle Scholar